SG:42C Stock Latest News
Company AnnouncementsShareholders Approve All Eight Resolutions at iX Biopharma AGM4d ago42C
Company AnnouncementsiX Biopharma details Wafermine milestones and U.S. compounding push ahead of AGM1M ago42C
Company AnnouncementsiX Biopharma Secures SGX Nod for Debt-for-Equity Share Listing1M ago42C
Company AnnouncementsiX Biopharma Moves to Convert A$1.7 Million Debt Into Equity1M ago42C
Company AnnouncementsiX Biopharma Rides DoD-Backed Wafermine Push and U.S. Expansion Strategy1M ago42C
Company AnnouncementsiX Biopharma Advances Wafermine as U.S. Opens Rare Military Emergency Use Pathway2M ago42C
Company AnnouncementsiX Biopharma Sets Final Timetable for Expiry and Delisting of SGX-Listed Warrants4M ago42C
Company AnnouncementsiX Biopharma Sets July 2026 Expiry for S$0.06 Warrants5M ago42C
Company AnnouncementsiX Biopharma Shifts Production Gear to U.S. to Support Wafermine Contract and Growth Push5M ago42C
Company AnnouncementsiX Biopharma Shareholders Approve New Share Issues and CEO Performance Award5M ago42CCompany AnnouncementsiX Biopharma Restructures Consumer Arm and Advances U.S. Joint Venture Plans6M ago42C
Company AnnouncementsiX Biopharma Clarifies Time-Based Vesting of Performance Shares Ahead of EGM6M ago42C
Company AnnouncementsiX Biopharma Wins Conditional SGX Nod for New Share Placement6M ago42C
Company AnnouncementsiX Biopharma Wins US$41 Million U.S. Contract to Advance Wafermine Pain Therapy9M ago42C
Company AnnouncementsiX Biopharma Wins US$41 Million U.S. Defense Contract for Non-Opioid Pain Drug9M ago42CCompany AnnouncementsiX Biopharma Earns Third Spot on Singapore’s Fastest Growing Companies List9M ago42C





